Mechanisms of renoprotective action of sodium-glucose cotransporter-2 inhibitors (gliflozins): a clinician’s view
Sodium-glucose cotransporter-2 inhibitors (SGLT2i) are a group of drugs that block the enzyme responsible for the reabsorption of glucose and sodium in the proximal part of the nephron. They appeared in clinical practice about a decade ago for the treatment of type 2 diabetes mellitus, but the first...
Main Authors: | Ya.M. Lutai, A.M. Parkhomenko |
---|---|
Format: | Article |
Language: | English |
Published: |
Zaslavsky O.Yu.
2023-03-01
|
Series: | Mìžnarodnij Endokrinologìčnij Žurnal |
Subjects: | |
Online Access: | https://iej.zaslavsky.com.ua/index.php/journal/article/view/1240 |
Similar Items
-
Adenosine/adenosine type 1 receptor signaling pathway did not play dominant roles on the influence of sodium–glucose cotransporter 2 inhibitor in the kidney of bovine serum albumin‐overloaded streptozotocin‐induced diabetic mice
by: Keiji Shimada, et al.
Published: (2022-06-01) -
Sodium–glucose cotransporters: Functional properties and pharmaceutical potential
by: Ryuhei Sano, et al.
Published: (2020-07-01) -
Renoprotective effect of additional sodium–glucose cotransporter 2 inhibitor therapy in type 2 diabetes patients with rapid decline and preserved renal function
by: Kentaro Sada, et al.
Published: (2022-08-01) -
Hyperurikemia in chronic kidney disease stage 4 — the issue of suitability of urate-lowering therapy
by: I.I. Melnyk
Published: (2023-03-01) -
Update on Pathogenesis of Glomerular Hyperfiltration in Early Diabetic Kidney Disease
by: Yang Yang, et al.
Published: (2022-05-01)